Osteoporosis: Burden, diagnosis, and management

Reginster, Jean-Yves; Bruyère, Olivier

doi:10.1002/9781119484288.ch77

Download

Contribution to collective works (Parts of books)

Osteoporosis: Burden, diagnosis, and management

Reginster, Jean-Yves; Bruyère, Olivier

2022 • In Pathy's Principles and Practice of Geriatric Medicine

Peer reviewed

Permalink
https://hdl.handle.net/2268/331712

DOI
10.1002/9781119484288.ch77

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Osteoporosis - burden, diagnosis and management_Reginster et al.pdf

Author postprint (1.35 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Ageing population; Fracture liaison services; Fragility fracture; Non-communicable diseases; Osteoporosis; Medicine (all)

Abstract :

[en] Osteoporosis (OP) is a major contributor to the global burden of disease and disability worldwide. Prevention and management of this disorder are of increasing importance, with pressure mounting from the ageing population. Studies that combined individuals with vertebral fractures who were either hospitalised or ambulatory indicated that the highest age-standardised rates were evident in South Korea, the US, and Hong Kong, while the lowest rate was in the UK. The burden associated with OP has been shown to be higher than for other common non-communicable diseases. There are data from Europe and the US demonstrating substantial disparities between the number of individuals at high fracture risk or who have experienced a low-trauma fracture and the number who receive appropriate assessment and treatment for OP. Fracture liaison services provide a system for the routine assessment and management of postmenopausal women and all men who have sustained a fragility fracture.

Disciplines :

Public health, health care sciences & services
Geriatrics

Author, co-author :

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique

Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Language :

English

Title :

Osteoporosis: Burden, diagnosis, and management

Publication date :

18 February 2022

Main work title :

Pathy's Principles and Practice of Geriatric Medicine

Publisher :

wiley

ISBN/EAN :

978-1-119-48428-8
978-1-119-48420-2

Peer reviewed :

Peer reviewed

Additional URL :

https://onlinelibrary.wiley.com/doi/pdf/10.1002/9781119484288.ch77

Available on ORBi :

since 14 May 2025

Statistics

Number of views

27 (1 by ULiège)

Number of downloads

15 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Xia W., et al. East meets West: current practices and policies in the management of musculoskeletal aging. Aging Clin Exp Res. 2019;31(10):1351-1373.
Kanis JA et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3-44.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-1858.
Rizzoli R et al. Management of osteoporosis of the oldest old. Osteoporos Int. 2014;25(11):2507-29.
Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15(11):897-902.
Oden A et al. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2013;92(1):42-9.
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726-33.
Oden A et al. Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int. 2015;26(9):2243-8.
Cauley JA et al. Official positions for FRAX(R) clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R). J Clin Densitom. 2011;14(3):240-62.
Ross PD et al. A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol. 1991;133(8):801-9.
Kanis JA et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239-56.
Ballane G et al. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017;28(5): 1531-1542.
Hernlund E et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.
Kanis JA et al. Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int. 2017; 28(7):2023-2034.
Freemantle N et al. Baseline observations from the POSSIBLE EU(R) study: characteristics of postmenopausal women receiving bone loss medications. Arch Osteoporos. 2010;5(1-2):61-72.
Cooper C et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277-88.
Johnell O et al. Latitude, socioeconomic prosperity, mobile phones and hip fracture risk. Osteoporos Int. 2007;18(3):333-7.
Rosengren BE et al. Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects. Osteoporos Int. 2017;28(1):139-149.
Johnell O et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38-42.
Ioannidis, G., et al. Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int. 2013;24(1):59-67.
Harvey NC., et al. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. 2017;28(5):1507-1529.
Klop C et al. Mortality in British hip fracture patients, 20002010: a population-based retrospective cohort study. Bone. 2014;66:171-7.
Hawley S et al. Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted timeseries analysis. J Bone Miner Res. 2016;31(11):2008-2015.
Greenspan SL et al. Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc. 2012;60(3):455-61.
Svedbom A et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137.
Harvey NCW., et al. Osteoporosis: treatment gaps and health economics. In: Huhtaniemi I, ed. Encyclopedia of Endocrine Diseases. Academic Press; 2019:288-295.
Mitchell P., et al. Implementation of models of care for secondary osteoporotic fracture prevention and orthogeriatric models of care for osteoporotic hip fracture. Best Pract Res Clin Rheumatol. 2016;30(3):536-558.
Drew S et al. Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery. Osteoporos Int. 2016;27(5):1719-27.
Kanis JA et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31(1):1-12.
Kanis JA et al. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Aging Clin Exp Res. 2019;31(1):15-17.
Kanis JA et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033-46.
Kanis JA et al. A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11(1):25.
Clark P, et al. FRAX-based intervention and assessment thresholds in seven Latin American countries. Osteoporos Int. 2018;29(3):707-715.
Kanis JA et al. Case finding for the management of osteoporosis with FRAX-- assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19(10):1395-408.
Tosteson AN et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19(4):437-47.
Shepstone L et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391(10122):741-747.
Beck BR et al. Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis. J Sci Med Sport. 2017;20(5):438-445.
Jensen AL et al. Effectiveness and characteristics of multifaceted osteoporosis group education-a systematic review. Osteoporos Int. 2014;25(4):1209-24.
Kemmler W, von Stengel S, Kohl M. Exercise frequency and fracture risk in older adults-how often is enough? Curr Osteoporos Rep. 2017;15(6):564-570.
de Souto Barreto P., et al. Association of long-term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults: a systematic review and metaanalysis. JAMA Intern Med. 2019;179(3):394-405.
Sherrington C et al. Exercise for preventing falls in older people living in the community: an abridged Cochrane systematic Review. Br J Sports Med. 2019.
McClung MR et al. Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years. Osteoporos Int. 2013;24(1):301-10.
Hiligsmann M et al. Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporos Int. 2019;30(11):2155-2165.